Evidence map›Paper›PMID 39044265›Full record

ArticleJournal of nanobiotechnology2024

NANO.PTML model for read-across prediction of nanosystems in neurosciences. computational model and experimental case of study.

Shan He, Karam Nader, Julen Segura Abarrategi, Harbil Bediaga, Deyani Nocedo-Mena, Estefania Ascencio, Gerardo M Casanola-Martin, Idoia Castellanos-Rubio, Maite Insausti, Bakhtiyor Rasulev and 2 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shan HeDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, 58108, USA.
Karam NaderDepartment of Organic and Inorganic Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain.
Julen Segura AbarrategiDepartment of Organic and Inorganic Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain.
Harbil BediagaIKERDATA S.L., ZITEK, UPV/EHU, Rectorate Building, nº 6, Leioa, 48940, Greater Bilbao, Basque Country, Spain.
Deyani Nocedo-MenaFaculty of Physical Mathematical Sciences, Autonomous University of Nuevo León, San Nicolás de los Garza, 66455, Nuevo León, México.
Estefania AscencioDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, 58108, USA.
Gerardo M Casanola-MartinDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, 58108, USA.
Idoia Castellanos-RubioDepartment of Organic and Inorganic Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain. idoia.castellanos@ehu.eus.
Maite InsaustiDepartment of Organic and Inorganic Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain.
Bakhtiyor RasulevDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, 58108, USA.
Sonia ArrasateDepartment of Organic and Inorganic Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain. sonia.arrasate@ehu.eus.
Humberto González-DíazDepartment of Organic and Inorganic Chemistry, University of Basque Country UPV/EHU, Leioa, 48940, Spain.

Funding

Center for Computationally-Assisted Science and Technology (CCAST) at North Dakota State University 2019077grants Basque Government / Eusko Jaurlaritza IT1558-22Ministry of Science and Innovation PID2022-137365NB-I00NextGenerationEU INVESTIGO 2022/IKER/000040Spanish Ministry of Science and Innovation PID2022- 136993OB-I00SPRI ELKARTEK grants AIMOFGIF KK-2022/00032U.S. Department of Energy (DOE) DE-SC0022239
6 · The paper itself

Abstract

Neurodegenerative diseases involve progressive neuronal death. Traditional treatments often struggle due to solubility, bioavailability, and crossing the Blood-Brain Barrier (BBB). Nanoparticles (NPs) in biomedical field are garnering growing attention as neurodegenerative disease drugs (NDDs) carrier to the central nervous system. Here, we introduced computational and experimental analysis. In the computational study, a specific IFPTML technique was used, which combined Information Fusion (IF) + Perturbation Theory (PT) + Machine Learning (ML) to select the most promising Nanoparticle Neuronal Disease Drug Delivery (N2D3) systems. For the application of IFPTML model in the nanoscience, NANO.PTML is used. IF-process was carried out between 4403 NDDs assays and 260 cytotoxicity NP assays conducting a dataset of 500,000 cases. The optimal IFPTML was the Decision Tree (DT) algorithm which shown satisfactory performance with specificity values of 96.4% and 96.2%, and sensitivity values of 79.3% and 75.7% in the training (375k/75%) and validation (125k/25%) set. Moreover, the DT model obtained Area Under Receiver Operating Characteristic (AUROC) scores of 0.97 and 0.96 in the training and validation series, highlighting its effectiveness in classification tasks. In the experimental part, two samples of NPs (Fe

Indexed as

NanoparticlesAlgorithmsAnimalsBlood-Brain BarrierComputer SimulationDrug CarriersDrug Delivery SystemsHumansMachine LearningNeurodegenerative DiseasesNeurosciencesDrug CarriersDrug carrierInformation fusionMachine learningNanoparticleNeurodegenerative disease

Identifiers

PMID39044265
PMCPMC11267683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.